Clinical Trial

A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma

Name: A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma — clinical trial record (NCT06739213)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, controlled, open-label, multicenter, Phase II clinical study designed to evaluate the efficacy and safety of SYHA1813 compared to investigators' choice in participants with recurrent or progressive high-grade meningioma.

Trial Details

NCT Number	NCT06739213
Lead Sponsor	Shanghai Runshi Pharmaceutical Technology Co., Ltd
Conditions	Recurrent or Progressive High Grade Meningioma
Enrollment	56 participants
Start Date	2025-01-31
Primary Completion	2027-01-31 (estimated)
Study Completion	2028-01-13 (estimated)
Updated on ClinicalTrials.gov	2024-12-18